Neoplasm Transplantation < Neoplasms < Neoplasms, Experimental

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Neoplasms

Number of relevant bibliographic references: 15.

Ident.	Authors (with country if any)	Title
000007 (2020)	Vasco Branco [Portugal] ; José Pimentel [Portugal] ; Maria Alexandra Brito [Portugal] ; Cristina Carvalho [Portugal]	Thioredoxin, Glutathione and Related Molecules in Tumors of the Nervous System.
000114 (2019)	Xiaoyuan Ren [Suède] ; Sebastin M. Santhosh [Suède] ; Lucia Coppo [Suède] ; Fernando T. Ogata [Suède] ; Jun Lu [République populaire de Chine] ; Arne Holmgren [Suède]	The combination of ascorbate and menadione causes cancer cell death by oxidative stress and replicative stress.
000159 (2019)	Federica Sotgia [Royaume-Uni] ; Marco Fiorillo [Royaume-Uni, Italie] ; Michael P. Lisanti [Royaume-Uni]	Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs).
000170 (2019)	Qing Ye [États-Unis] ; Yinan Zhang [République populaire de Chine] ; Yanan Cao [États-Unis] ; Xiachang Wang [République populaire de Chine] ; Yubin Guo [États-Unis] ; Jing Chen [États-Unis] ; Jamie Horn [États-Unis] ; Larissa V. Ponomareva [États-Unis] ; Luksana Chaiswing [États-Unis] ; Khaled A. Shaaban [États-Unis] ; Qiou Wei [États-Unis] ; Bradley D. Anderson [États-Unis] ; Daret K. St Clair [États-Unis] ; Haining Zhu [États-Unis] ; Markos Leggas [États-Unis] ; Jon S. Thorson [États-Unis] ; Qing-Bai She [États-Unis]	Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects.
000216 (2018)	Guangshan Zhao [République populaire de Chine] ; Ximing Wu [République populaire de Chine] ; Pingping Chen [République populaire de Chine] ; Lingyun Zhang [République populaire de Chine] ; Chung S. Yang [États-Unis] ; Jinsong Zhang [République populaire de Chine]	Selenium nanoparticles are more efficient than sodium selenite in producing reactive oxygen species and hyper-accumulation of selenium nanoparticles in cancer cells generates potent therapeutic effects.
000389 (2017)	Kerstin N. Timm ; De-En Hu ; Michael Williams ; Alan J. Wright ; Mikko I. Kettunen ; Brett W C. Kennedy ; Timothy J. Larkin ; Piotr Dzien ; Irene Marco-Rius ; Sarah E. Bohndiek [Royaume-Uni] ; Kevin M. Brindle [Royaume-Uni]	Assessing Oxidative Stress in Tumors by Measuring the Rate of Hyperpolarized [1-13C]Dehydroascorbic Acid Reduction Using 13C Magnetic Resonance Spectroscopy.
000512 (2015)	Manuela Gellert [Allemagne] ; Eva-Maria Hanschmann [Allemagne] ; Klaudia Lepka [Allemagne] ; Carsten Berndt [Allemagne] ; Christopher Horst Lillig [Allemagne]	Redox regulation of cytoskeletal dynamics during differentiation and de-differentiation.
000608 (2014)	E V Kalinina [Russie] ; N N Chernov ; M D Novichkova	Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes.
000619 (2014)	Y. Zhang [Royaume-Uni] ; S G Martin [Royaume-Uni]	Redox proteins and radiotherapy.
000686 (2014)	Danyelle M. Townsend [États-Unis] ; Volodymyr I. Lushchak [Ukraine] ; Arthur J L. Cooper [États-Unis]	A comparison of reversible versus irreversible protein glutathionylation.
000A93 (2009)	Mee-Kyung Cha [Corée du Sud] ; Il-Han Kim	Preferential overexpression of glutaredoxin3 in human colon and lung carcinoma.
000B91 (2008)	John J. Mieyal [États-Unis] ; Molly M. Gallogly ; Suparna Qanungo ; Elizabeth A. Sabens ; Melissa D. Shelton	Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.
000C09 (2008)	Maria Elisabet Lönn [Suède] ; Christoph Hudemann ; Carsten Berndt ; Valeria Cherkasov ; Francisco Capani ; Arne Holmgren ; Christopher Horst Lillig	Expression pattern of human glutaredoxin 2 isoforms: identification and characterization of two testis/cancer cell-specific isoforms.
000C52 (2007)	Jun Lu [Suède] ; Eng-Hui Chew ; Arne Holmgren	Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.
000D77 (2005)	John E. Biaglow [États-Unis] ; Richard A. Miller	The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Neoplasms" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Neoplasms" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    GlutaredoxinV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Neoplasms
}}

---

This area was generated with Dilib version V0.6.37. Data generation: Wed Nov 18 15:13:42 2020. Site generation: Wed Nov 18 15:16:12 2020